What's Wrong With UnitedHealth Stock?

Source Motley_fool

Key Points

  • UnitedHealth reported earnings recently, which beat on the bottom line but missed on revenue.

  • The company's guidance is soft for the year ahead as management expects a decline.

  • The Trump administration has proposed just a nominal increase in Medicare Advantage rates for 2027.

  • 10 stocks we like better than UnitedHealth Group ›

UnitedHealth Group (NYSE: UNH) is a stock that looks to be in deep trouble. As of the end of January, it was already down 13% in 2026. And that's after an already brutal year in 2025, when it fell 35% in value. Investors have been dumping the stock in droves, as things appear to be going from bad to worse.

The company recently released its latest quarterly results, which only exacerbated concerns about its future and whether this is still a good business to invest in. Here's why UnitedHealth stock seems to be in an endless free fall these days, and whether you should consider taking a chance on it.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

Frustrated investor looking at stocks.

Image source: Getty Images.

What's weighing down UnitedHealth stock?

UnitedHealth reported its fourth-quarter results last week, and they technically weren't all that bad. The company beat expectations on the bottom line as its adjusted earnings per share came in at $2.11 versus the $2.10 that analysts were projecting. The company's top line was a little weak, however, totaling $113.2 billion, which was slightly lower than the $113.82 billion that Wall Street was looking for.

It was a slight miss on revenue, but the bigger concern is that the future may not be all that much more promising for UnitedHealth. The Trump administration is proposing that rates are flat for Medicare Advantage in 2027, which is bad news not only for UnitedHealth, but other health insurance companies as well. Analysts were expecting rates to increase by at least 4%, while the government proposal calls for a rate increase of just 0.09%.

This is already as UnitedHealth is struggling to grow in 2026. For the current year, it forecasts revenue to be around $439 billion, which would represent a year-over-year decline of 2%.

A recovery may not be coming this year

There's a lot of attention these days on high healthcare costs, which is why I'm not optimistic that UnitedHealth's stock will experience a quick turnaround. For years, this has been a strong growth stock to own as the company has been doing well on both its top and bottom lines. That simply may not be the case anymore, at least in the short term. UnitedHealth has been struggling with rising utilization rates and higher medical costs, and now, it's looking as though it will be difficult to generate much revenue growth as well.

All in all, it doesn't paint a terribly exciting picture for the healthcare stock. At the very least, you'll need to be extremely patient with it, because there's no reason, unfortunately, to expect things to get better for UnitedHealth in the near future.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $446,319!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,137,827!*

Now, it’s worth noting Stock Advisor’s total average return is 932% — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of February 3, 2026.

David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Is This The Bitcoin Bottom? 3 Metrics Still Point To $63,000 As The Key Risk ZoneThe Bitcoin price has seen one of its sharpest pullbacks in months, losing over 11% since its late-January peak. While the price has reached a major technical target, on-chain and derivatives data sug
Author  Beincrypto
Feb 02, Mon
The Bitcoin price has seen one of its sharpest pullbacks in months, losing over 11% since its late-January peak. While the price has reached a major technical target, on-chain and derivatives data sug
placeholder
Gold Price Forecast: XAU/USD rebounds above $4,800, traders brace for US-Iran talks Gold price (XAU/USD) recovers some lost ground to near $4,820 during the early Asian session on Tuesday. The precious metal edges higher following a historic market rout.
Author  Rachel Weiss
Yesterday 02: 04
Gold price (XAU/USD) recovers some lost ground to near $4,820 during the early Asian session on Tuesday. The precious metal edges higher following a historic market rout.
placeholder
Gold Recovers from Losses as Market Adjusts to Warsh's Fed Nomination and Easing Geopolitical Tensions Gold prices surged in early Asian trading, rebounding 2.7% following two days of losses as the market adjusted to Kevin Warsh's Fed nomination and diminishing U.S.-Iran tensions. Investors await key U.S. payroll data.
Author  Mitrade
Yesterday 03: 04
Gold prices surged in early Asian trading, rebounding 2.7% following two days of losses as the market adjusted to Kevin Warsh's Fed nomination and diminishing U.S.-Iran tensions. Investors await key U.S. payroll data.
placeholder
Bitcoin ETF Investors Face 8% Losses as $3 Billion Exits Market in Two WeeksUS spot Bitcoin ETF buyers are essentially the very investors expected to provide a stable, long-term bid for the pioneer crypto. However, data shows that these players are now sitting on mounting unr
Author  Beincrypto
20 hours ago
US spot Bitcoin ETF buyers are essentially the very investors expected to provide a stable, long-term bid for the pioneer crypto. However, data shows that these players are now sitting on mounting unr
placeholder
Gold Prices Surge Amid Rising U.S.-Iran Tensions, Driving Safe-Haven Demand to New HeightsGold prices rebounded Wednesday, climbing 0.9% to $4,995.60 an ounce as geopolitical tensions between the U.S. and Iran heightened demand for safe-haven assets, despite recent market volatility.
Author  Mitrade
2 hours ago
Gold prices rebounded Wednesday, climbing 0.9% to $4,995.60 an ounce as geopolitical tensions between the U.S. and Iran heightened demand for safe-haven assets, despite recent market volatility.
goTop
quote